NorthWest Biotherapeutics Inc (NWBO): hyperopia, I was not thinking of Char...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

NorthWest Biotherapeutics Inc (NWBO)

Reply Private New

Keep Last Read

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	169
Posts	13905
Boards Moderated	1
Alias Born	01/26/2016

Re: hyperopia post# 485984

Sunday, 06/12/2022 9:41:42 PM

Sunday, June 12, 2022 9:41:42 PM

hyperopia,

I was not thinking of Charles River Labs leapfrogging with the Eden device, rather I was thinking they would be helping to meet current manual demand. They have a license and if flipper44 is correct about biopsy only being able to be used for the lysate, the demand will be well beyond current manual capacity at Sawston and would help explain the very significant buildout at Memphis. Best wishes.

Keep Last Read

Replies (2) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent NWBO News

Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2024 09:24:13 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM

More NWBO News

InvestorsHub NewsWire

SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM

DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM

SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM

Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM

SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM

VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow